✦ LIBER ✦

First-line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

✍ Scribed by G. B. Kristensen; I. Vergote; G. Stuart; J. M. Del Campo; J. Kaern; A. B. Lopez; E. Eisenhauer; E. Aavall-Lundquist; M. Ridderheim; H. Havsteen; M. R. Mirza; M. Scheistroen; E. Vrdoljak

Book ID: 109085259
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 101 KB
Volume: 13
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2003.13363.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin/paclitaxel/carboplatin (TEC)

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial

✍ E. PUJADE-LAURAINE; A. du BOIS; A. GOUPIL; J. ROCHON; V. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

First-line treatment of ovarian/tubal/pe

First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB–IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival

✍ G.B. KRISTENSEN; I. VERGOTE; G. STUART; J.M. Del CAMPO; J. KÆRN; M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase II feasibility study of carbopla

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

A phase II study of outpatient first-lin

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

✍ J.P. MICHA; B.H. GOLDSTEIN; M.A. RETTENMAIER; M. GENESEN; C. GRAHAM; K. BADER; K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Novel treatment of ovarian cancer cell l

Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects

✍ Christoph Mundhenke; Marion Tina Weigel; Klarissa Hanja Sturner; Frank Roesel; I 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 505 KB